SOPHiA GENETICS S.A.
SOPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.15 | 0.38 | -0.08 | -0.14 |
| FCF Yield | -25.15% | -18.95% | -60.94% | -7.18% |
| EV / EBITDA | -2.96 | -2.83 | 0.15 | -10.17 |
| Quality | ||||
| ROIC | -51.95% | -43.40% | -39.43% | -24.27% |
| Gross Margin | 67.42% | 68.80% | 65.71% | 62.35% |
| Cash Conversion Ratio | 0.70 | 0.62 | 0.80 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.07% | 15.53% | 18.75% | 16.84% |
| Free Cash Flow Growth | 11.77% | 28.17% | -24.55% | -84.95% |
| Safety | ||||
| Net Debt / EBITDA | 0.97 | 1.48 | 1.75 | 2.54 |
| Interest Coverage | -34.80 | -127.26 | -137.44 | -108.65 |
| Efficiency | ||||
| Inventory Turnover | 3.62 | 3.00 | 3.16 | 2.66 |
| Cash Conversion Cycle | 116.32 | 168.25 | 128.64 | 145.27 |